MW
Congress trade
Sen. Mark Warner (D-VA) sold $500K-$1M of Halozyme Therapeutics, Inc. (HALO) stock
Mark Warner, U.S. Senator (D-VA), disclosed a sale of Halozyme Therapeutics, Inc. (HALO) stock worth $500K-$1M in a STOCK Act filing on Dec 8, 2017.
The trade happened on Nov 6, 2017, 32 days before it was made public.
HALO has moved +569.6% since the trade date, from $17.01 to $113.90 (Sep 25, 2026 close).
- Traded
- Nov 6, 2017
- Disclosed
- Dec 8, 2017
- Filing delay
- 32 days
- Price since
- +569.6%
- Source
- STOCK Act disclosure
More HALO insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.